Swedish diagnostics firm Gradientech is proud to announce the appointment of three internationally renowned members to the company’s scientific advisory board, SAB. With their expertise in clinical microbiology, the new advisors will provide valuable support in preparing for a successful market launch of Gradientech’s in vitro diagnostic system for ultra-rapid antibiotic susceptibility testing, claimed to be the fastest among new systems in development.
Gradientech AB (publ) interim report for Q3 2020 is now available in Swedish on the company’s website www.gradientech.se.
Gradientech AB (publ) delårsrapport för Q3 2020 är nu tillgänglig på bolagets hemsida www.gradientech.se.
Gradientech AB (publ) delårsrapport för Q2 2020 är nu tillgänglig på bolagets hemsida www.gradientech.se.
Innovative Swedish diagnostics company Gradientech announces closure of an oversubscribed financing round totalling $9 million (SEK 80 million). The round was executed by a combination of existing shareholders and several new investors appointed by Swedish financial advisor, Redeye. Bird & Bird Lawyers acted as legal advisors.
Gradientech will be presenting its QuickMIC system at the sixth edition of the Infection Week & Microbiological Spring Meeting.
Gradientech kommer att presentera sitt QuickMIC-system vid den sjätte upplagan av Infektionsveckan och mikrobiologiskt vår/höstmöte i Uppsala.
Gradientech AB (publ) interim report for Q2 2020 is now available in Swedish on the company’s website www.gradientech.se.
Gradientech is pleased to announce that the QuickMIC® instrument, which is part of the antibiotic susceptibility testing system in development by Gradientech, is now approved for research use after extensive testing by Intertek. The QuickMIC instrument fulfils the IEC, UL and FCC standards for electrical safety, basic safety and electromagnetic compatibility (EMC), which certifies the instrument to be used by external customers within the European countries and the US.
The pilot study, led by Gradientech, combined rapid ID+AST technologies – T2Bacteria (ID) and QuickMIC (AST) and compared the time-to-result to a workflow using standard laboratory methods.